Millennium Management
PDLI

Millennium Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Millennium Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-25,600
Closed -$54K – 4150
2016
Q4 		$54K Buy
+25,600
New +$71.4K ﹤0.01% 3246

Other funds holding PDLI

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
WG
Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Millennium Management's PDLI Position: Q4 2020 in Review

Millennium Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2020, closing a stake of 45,861 shares — an estimated $144 sold.

Millennium Management first reported a position in PDLI in Q2 2013 and held it in 29 quarters. The position peaked at $11.9M in Q3 2017. 33 funds tracked by Wall St. Rank hold PDLI as of Q4 2020.

  • Millennium Management reported no remaining PDL BioPharma, Inc. position as of Q4 2020 after selling out during the quarter.
  • Millennium Management sold 45,861 PDL BioPharma, Inc. shares in Q4 2020, an estimated $144.
  • Millennium Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 29 quarters.
  • Millennium Management's PDL BioPharma, Inc. position peaked at $11.9M in Q3 2017.
  • 33 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2020.

Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.